hydroxychloroquine has been researched along with Chronic Progressive Multiple Sclerosis in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a recent trial, hydroxychloroquine (HCQ) treatment reduced the expected rate of disability worsening at 18 months in primary progressive multiple sclerosis (PPMS)." | 8.31 | Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis. ( Camara-Lemarroy, C; Gohill, J; Koch, M; Silva, C; Yong, VW, 2023) |
| "In a recent trial, hydroxychloroquine (HCQ) treatment reduced the expected rate of disability worsening at 18 months in primary progressive multiple sclerosis (PPMS)." | 4.31 | Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis. ( Camara-Lemarroy, C; Gohill, J; Koch, M; Silva, C; Yong, VW, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, MW | 1 |
| Kaur, S | 1 |
| Sage, K | 1 |
| Kim, J | 1 |
| Levesque-Roy, M | 1 |
| Cerchiaro, G | 1 |
| Yong, VW | 2 |
| Cutter, GR | 1 |
| Metz, LM | 1 |
| Camara-Lemarroy, C | 1 |
| Silva, C | 1 |
| Gohill, J | 1 |
| Koch, M | 1 |
1 trial available for hydroxychloroquine and Chronic Progressive Multiple Sclerosis
| Article | Year |
|---|---|
Hydroxychloroquine for Primary Progressive Multiple Sclerosis.
Topics: Disease Progression; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Magnetic Resonanc | 2021 |
1 other study available for hydroxychloroquine and Chronic Progressive Multiple Sclerosis
| Article | Year |
|---|---|
Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis.
Topics: Biomarkers; Clinical Trials, Phase II as Topic; Glial Fibrillary Acidic Protein; Humans; Hydroxychlo | 2023 |